查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1965969

可吸收聚合物市场－全球产业规模、份额、趋势、机会、预测：按类型、应用、区域和竞争格局划分，2021-2031年

Resorbable Polymers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球可吸收（生物可吸收）聚合物市场预计将从 2025 年的 4.8343 亿美元成长到 2031 年的 6.4452 亿美元，复合年增长率为 4.91%。

这些特殊的生物降解材料旨在人体内安全分解，有效避免组织癒合后再次手术取出金属植入物。推动这一市场成长的关键因素包括全球人口老化导致慢性病发病率上升，以及微创医疗技术的日益普及。在整形外科固定和控释药物等应用中，这些聚合物可在人体自然代谢前提供临时结构支撑，从而展现出比永久性金属植入更显着的临床优势。

市场概览
预测期 2027-2031
市场规模：2025年 4.8343亿美元
市场规模：2031年 6.4452亿美元
复合年增长率：2026-2031年 4.91%
成长最快的细分市场 整形外科
最大的市场 北美洲

儘管需求依然强劲，但医用级认证所需的严格且高成本的监管程序仍构成重大障碍。製造商必须遵守复杂的合规框架，这往往会导致产品商业化进程的延迟。根据欧洲生质塑胶协会预测，到2024年，包括聚乳酸等重要吸收材料在内的全球生质塑胶产能将达到约247万吨。这一数字显示供应链稳健，但严格的临床检验要求仍限制创新聚合物技术在医疗领域的应用速度。

市场驱动因素

从金属医疗植入向生物可吸收植入的转变正在从根本上改变市场格局，因为它消除了取出等二次手术的必要性。由于这些聚合物可在体内无害分解，因此避免了钛和钢植入通常需要的后续取出手术所带来的临床风险和医疗成本。这一显着的临床优势正在推动其在运动医学和整形外科固定领域的广泛应用，在这些领域，临时加固足以促进骨骼恢復。为了支持这项不断增长的产业需求，Corbion 在 2024 年 3 月发布的 2023 财年年度报告中指出，其生物医用聚合物部门维持了两位数的成长，凸显了创伤治疗和缓释应用领域对生物可吸收材料日益增长的需求。

同时，支架技术和3D生物列印技术的进步正推动市场成长，因为它们能够生产高度个人化的组织结构。先进的积层製造技术可以製造出多孔、可吸收的结构，这些结构旨在模拟天然软组织，并在代谢之前促进再生。根据BellaSeno公司2024年8月发布的关于其临床计画的媒体稿，该公司使用3D列印的可吸收支架成功治疗了41名患者，证明了这些新一代植入的安全性和有效性。更广泛的产业格局也支持这种扩充性；根据塑胶工业协会2024年的估计，光是北美就占全球生质塑胶产能的18.7%，这确保了这些快速成长的医疗技术所需的可靠材料供应。

市场挑战

获得医用级认证所需的高成本和繁琐的监管流程是全球可吸收（生物可吸收）聚合物市场扩张的主要障碍。製造商必须应对日益复杂的合规环境，尤其是在要求提供全面技术文件和临床数据的严格框架下。这种监管状况给新型聚合物医疗设备带来了沉重的经济负担，并延长了产品上市时间。这直接阻碍了创新，并使缺乏资金来应对这些漫长流程的中小型企业难以进入市场。

这些更严格标准的影响是严重且可量化的。据欧洲医疗技术协会（MedTech Europe）称，根据医疗设备法规（MDR），到2024年，认证和维修成本将比先前的指令高出100%。成本的急剧上升和显着的延误迫使各机构将资金从研发活动重新分配到合规义务。因此，儘管临床对这些材料有需求，但先进吸收性聚合物技术的应用却被延缓，限制了商业性化供应，并抑制了整体市场发展动能。

市场趋势

可吸收聚合物在永续包装领域的应用正蓬勃发展，其应用范围已超越医疗领域，协助实现全球循环经济目标。与低产量、高利润的医疗产业不同，此趋势的特征是聚乳酸（PLA）等材料的大规模工业化生产，推动一次性产品中化石基塑胶的替代方案。领先的製造商正积极筹集资金筹措，以增强产能，并巩固向可堆肥替代品的转型，从而最大限度地减少环境残留。例如，在2024年5月题为「Ingeo PLA生产扩建计画获得创纪录融资」的新闻稿中，NatureWorks宣布已获得126亿泰铢的企业联合贷款，用于在泰国建设一座全新的全集成生物聚合物生产基地，从而确保非医疗应用领域的稳定供应。

此外，用于高级创伤护理的静电纺丝奈米纤维的开发代表着一项重大的技术进步，它采用高表面积基质，能够与癒合环境积极相互作用。与3D列印整形外科植入提供的结构加固不同，这些奈米纤维敷料专为溃疡和烧烫伤的局部治疗而设计，透过精确调节pH值和吸收渗出液，实现感染控制等功能。该技术能够建构生物工程合成基质，透过优化伤口床的酸度来促进伤口癒合。根据发表在2024年10月《医疗产品外包》（Medical Product Outsourcing）杂誌上的报导《Royal Wound-X推出两项新的创伤治疗技术》，该公司的新型“ElectroFiber 3D”支架已被证实可在78小时内将伤口pH值从7.4降低至5.9，有效降低至细菌生长并促进组织再生。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：可吸收（生物可吸收）聚合物的全球市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依类型（农业聚合物、生物聚酯、其他）
    • 依应用领域（整形外科、心臟植入、牙科植入、口服药物传输等）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美可吸收（生物可吸收）聚合物市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲可吸收（生物可吸收）聚合物市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区可吸收（生物可吸收）聚合物市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲可吸收（生物可吸收）聚合物市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲可吸收（生物可吸收）聚合物市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球可吸收（生物可吸收）聚合物市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Corbion NV
  • Poly-Med, Inc.
  • Foster Corporation
  • Evonik Industries AG
  • KLS-Martin Limited
  • 3d Biotek LLC
  • Degradable solutions AG
  • Koninklijke DSM NV
  • FUTERRO SA
  • Abbott Laboratories Inc

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 3828

The Global Resorbable (Bioresorbable) Polymers Market is projected to expand from USD 483.43 Million in 2025 to USD 644.52 Million by 2031, reflecting a compound annual growth rate of 4.91%. These specialized biodegradable materials are engineered to decompose safely within the human body, effectively negating the necessity for secondary surgeries to remove hardware after tissues have healed. Key drivers accelerating this market growth include the increasing incidence of chronic diseases within an aging global population and a growing inclination toward minimally invasive medical techniques. In applications such as orthopedic fixation and controlled drug delivery, these polymers offer a distinct clinical benefit over permanent metal implants by providing temporary structural support before being naturally metabolized.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 483.43 MIllion
Market Size 2031USD 644.52 MIllion
CAGR 2026-20314.91%
Fastest Growing SegmentOrthopedics
Largest MarketNorth America

Despite strong demand, the industry faces substantial hurdles related to the rigorous and expensive regulatory procedures needed for medical-grade certification. Manufacturers are required to maneuver through complicated compliance frameworks, which often results in delays to product commercialization. According to European Bioplastics, the global production capacity for bioplastics-including essential resorbable materials like polylactic acid-reached roughly 2.47 million tonnes in 2024. Although this figure suggests a robust supply chain, the strict demands for clinical validation continue to restrict the pace at which innovative polymer technologies can penetrate the medical sector.

Market Driver

The transition from metallic to bioresorbable medical implants is fundamentally transforming the market by eliminating the need for secondary surgical procedures to remove hardware. Because these polymers degrade harmlessly inside the body, they eradicate the clinical risks and healthcare expenditures associated with the follow-up extraction surgeries often required for titanium or steel implants. This distinct clinical advantage is fostering significant adoption in sports medicine and orthopedic fixation, where temporary reinforcement is adequate for bone recovery. Validating this accelerated industrial demand, Corbion reported in its 'Annual Report 2023' in March 2024 that its biomedical polymers division sustained a double-digit growth trajectory, highlighting the rising need for resorbable materials in trauma management and controlled release sectors.

Concurrently, technological advancements in scaffolding and 3D bioprinting are driving market growth by facilitating the production of highly personalized tissue constructs. Advanced additive manufacturing enables the fabrication of porous resorbable structures designed to simulate natural soft tissue, thereby promoting regeneration prior to metabolization. According to a press statement by BellaSeno in August 2024 regarding its clinical program, the safety and efficacy of these next-generation implants were demonstrated through the successful treatment of 41 patients with the company's 3D-printed resorbable scaffolds. The broader industrial landscape supports this scalability, as the Plastics Industry Association estimated in 2024 that North America alone contributed 18.7% of the global bioplastics production capacity, ensuring a reliable material supply for these burgeoning medical technologies.

Market Challenge

The expensive and stringent regulatory process required to obtain medical-grade certification stands as a major barrier to the expansion of the Global Resorbable (Bioresorbable) Polymers Market. Manufacturers must navigate a compliance landscape that is becoming increasingly intricate, particularly under stricter frameworks that necessitate comprehensive technical documentation and clinical data. This regulatory environment imposes a significant financial load and extends the time-to-market for new polymer-based devices, which directly inhibits innovation and discourages market entry for smaller companies lacking the capital to manage these prolonged processes.

The consequences of these elevated standards are both severe and quantifiable. According to MedTech Europe, certification and maintenance costs under the Medical Device Regulation surged by up to 100% in 2024 compared to earlier directives. Such escalating costs and extensive delays force organizations to redirect capital from research and development efforts toward compliance obligations. As a result, the deployment of advanced resorbable polymer technologies is slowed, limiting their commercial availability and suppressing overall market momentum, even in the face of underlying clinical demand for these materials.

Market Trends

The utilization of bioresorbable polymers is gaining momentum in sustainable packaging as the market expands beyond medical uses to meet global circular economy goals. In contrast to the low-volume, high-margin medical industry, this trend is defined by a massive industrial scaling of materials such as polylactic acid (PLA) to supersede fossil-based plastics in single-use products. Leading producers are obtaining significant capital to enhance manufacturing capacities, confirming the transition toward compostable alternatives that minimize environmental persistence. For instance, NatureWorks announced in a May 2024 press release titled 'Ingeo PLA Manufacturing Expansion Attracts Record Financing' that it had secured a syndicated loan of 12.6 billion THB to finance a new fully integrated biopolymer manufacturing complex in Thailand, ensuring a steady supply for these non-medical applications.

Furthermore, the development of electrospun nanofibers for advanced wound care marks a crucial technical evolution, employing high-surface-area matrices to actively influence the healing environment. Unlike the structural reinforcement offered by 3D-printed orthopedic implants, these nanofibrous dressings are engineered for the topical treatment of ulcers and burns, providing functions such as infection control and exudate absorption via precise pH regulation. This technology facilitates the generation of bioengineered synthetic matrices that hasten closure rates by optimizing the acidity of the wound bed. According to an October 2024 article in Medical Product Outsourcing titled 'Royal Wound-X Launches Two New Wound Healing Technologies', the company's new ElectroFiber 3D scaffold proved capable of lowering wound pH from 7.4 to 5.9 within 78 hours, effectively inhibiting bacterial growth while encouraging tissue regeneration.

Key Market Players

  • Corbion NV
  • Poly-Med, Inc.
  • Foster Corporation
  • Evonik Industries AG
  • KLS-Martin Limited
  • 3d Biotek LLC
  • Degradable solutions AG
  • Koninklijke DSM N.V.
  • FUTERRO S.A.
  • Abbott Laboratories Inc

Report Scope

In this report, the Global Resorbable (Bioresorbable) Polymers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Resorbable (Bioresorbable) Polymers Market, By Type

  • Agro-Polymers
  • Biopolyesters
  • Others

Resorbable (Bioresorbable) Polymers Market, By Application

  • Orthopedics
  • Cardiac Implants
  • Dental Implants
  • Oral Drug Delivery
  • Others

Resorbable (Bioresorbable) Polymers Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Resorbable (Bioresorbable) Polymers Market.

Available Customizations:

Global Resorbable (Bioresorbable) Polymers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Resorbable (Bioresorbable) Polymers Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Agro-Polymers, Biopolyesters, Others)
    • 5.2.2. By Application (Orthopedics, Cardiac Implants, Dental Implants, Oral Drug Delivery, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Resorbable (Bioresorbable) Polymers Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Resorbable (Bioresorbable) Polymers Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Resorbable (Bioresorbable) Polymers Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Resorbable (Bioresorbable) Polymers Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Resorbable (Bioresorbable) Polymers Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Resorbable (Bioresorbable) Polymers Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Resorbable (Bioresorbable) Polymers Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Resorbable (Bioresorbable) Polymers Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Resorbable (Bioresorbable) Polymers Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Resorbable (Bioresorbable) Polymers Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Resorbable (Bioresorbable) Polymers Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Resorbable (Bioresorbable) Polymers Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Resorbable (Bioresorbable) Polymers Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Resorbable (Bioresorbable) Polymers Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Resorbable (Bioresorbable) Polymers Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Resorbable (Bioresorbable) Polymers Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Resorbable (Bioresorbable) Polymers Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Resorbable (Bioresorbable) Polymers Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Resorbable (Bioresorbable) Polymers Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Resorbable (Bioresorbable) Polymers Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Resorbable (Bioresorbable) Polymers Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Resorbable (Bioresorbable) Polymers Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Resorbable (Bioresorbable) Polymers Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Resorbable (Bioresorbable) Polymers Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Resorbable (Bioresorbable) Polymers Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Corbion NV
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Poly-Med, Inc.
  • 15.3. Foster Corporation
  • 15.4. Evonik Industries AG
  • 15.5. KLS-Martin Limited
  • 15.6. 3d Biotek LLC
  • 15.7. Degradable solutions AG
  • 15.8. Koninklijke DSM N.V.
  • 15.9. FUTERRO S.A.
  • 15.10. Abbott Laboratories Inc

16. Strategic Recommendations

17. About Us & Disclaimer